阅读说明：本技术 一种去除四丁基氟化铵的方法 (Method for removing tetrabutylammonium fluoride ) 是由 康园园 李燕 崔明欣 耿佩佩 姚峰 于 2021-08-19 设计创作，主要内容包括：一种去除四丁基氟化铵的方法,属于核苷领域。该去除四丁基氟化铵的方案能够被用于制备目标核苷,且制备方法包括：利用硅保护基团对核苷起始物进行选定位的羟基保护,形成核苷修饰物；对所述核苷修饰物进行化学反应,以制备携带对所述选定位的羟基进行保护的所述硅保护基团的核苷前体；采用四丁基氟化铵脱除所述核苷前体中的所述硅保护基团并经水解,获得至少含有所述目标核苷和四丁基季铵盐的待分离物；利用阳离子交换树脂从所述待分离物中将所述四丁基季铵盐分离,获得所述目标核苷。该方案可以简便对在核苷的制备过程中去除四丁基氟化铵。(A method for removing tetrabutylammonium fluoride, belonging to the field of nucleosides. The scheme for removing tetrabutylammonium fluoride can be used for preparing target nucleosides, and the preparation method comprises the following steps: hydroxyl protection of selective positioning is carried out on the nucleoside starting material by utilizing a silicon protecting group to form a nucleoside modifier; chemically reacting said nucleoside modifications to produce nucleoside precursors bearing said silicon protecting groups protecting said selected hydroxyl groups; removing the silicon protecting group in the nucleoside precursor by adopting tetrabutylammonium fluoride, and hydrolyzing to obtain a to-be-separated substance at least containing the target nucleoside and tetrabutyl quaternary ammonium salt; and separating the tetrabutyl quaternary ammonium salt from the object to be separated by using cation exchange resin to obtain the target nucleoside. The scheme can be used for removing tetrabutylammonium fluoride in the preparation process of the nucleoside easily.)

1. A method of preparing a target nucleoside, comprising:

hydroxyl protection of selective positioning is carried out on the nucleoside starting material by utilizing a silicon protecting group to form a nucleoside modifier;

chemically reacting said nucleoside modifications to produce nucleoside precursors bearing said silicon protecting groups protecting said selected hydroxyl groups;

removing the silicon protecting group in the nucleoside precursor by adopting tetrabutylammonium fluoride, and hydrolyzing to obtain a to-be-separated substance at least containing the target nucleoside and tetrabutyl quaternary ammonium salt;

and separating the tetrabutyl quaternary ammonium salt from the object to be separated by using cation exchange resin to obtain the target nucleoside.

2. The method of claim 1, wherein the target nucleoside is a mononucleoside, an oligonucleotide formed by polymerization of a mononucleoside, a polynucleotide formed by polymerization of a mononucleoside, or a derivative of any one of the foregoing; wherein the base moiety of said mononucleoside comprises is adenine, guanine, cytosine, thymine, uracil or an unnatural base.

3. The method of claim 1, wherein the silicon protecting group comprises TMS, TES, TBDMS, TIPS, TIPDS or TBDPS;

or when a plurality of selected-site hydroxyl groups are protected by the silicon protecting groups, each silicon protecting group is independently selected from any one of TMS, TES, TBDMS, TIPS, TIPDS and TBDPS;

alternatively, the hydroxyl groups of the selected positions include any one or more of 2 ', 3 ' and 5 '.

4. The method according to any one of claims 1 to 3, wherein the step of separating the target nucleoside from the tetrabutyl ammonium salt from the isolate using a cation exchange resin comprises: and carrying out column chromatography by using the cation exchange resin.

5. Use of a cation exchange resin as adsorbent for removing tetrabutylammonium from a mixture containing at least nucleosides and tetrabutylammonium.

6. A method for removing tetrabutylammonium fluoride, which is used for purifying a nucleoside modifier with hydroxyl protected by a silicon protecting group after the silicon protecting group is removed by tetrabutylammonium fluoride, and is characterized in that the method comprises the following steps:

the mixture obtained after removal of the silicon protecting group and after hydrolysis is mixed with a cation exchange resin.

7. The method for removing tetrabutylammonium fluoride as claimed in claim 6, wherein said nucleoside modification is reacted in a tetrahydrofuran solution of tetrabutylammonium fluoride to remove said silicon protecting group, followed by hydrolysis to obtain said mixture.

8. The method for removing tetrabutylammonium fluoride according to claim 6 or 7, wherein the mixture is subjected to column chromatography using the cation exchange resin as a stationary phase and water as a mobile phase, so that tetrabutylammonium is adsorbed and attached to the cation exchange resin and nucleosides are eluted into a lower column solution.

9. The method for removing tetrabutylammonium fluoride according to claim 8, wherein the amount of said cation exchange resin used is 3 to 5 times the mass of nucleosides in said mixture; and/or, during elution, directly flowing through the cation exchange resin chromatography column with an eluent.

10. The method for removing tetrabutylammonium fluoride according to claim 6, wherein the yield of nucleosides is above 50%; alternatively, the yield of the nucleoside is 65% to 70%.

Technical Field

The application relates to the field of nucleosides, in particular to a method for removing tetrabutylammonium fluoride.

Background

Tetrabutylammonium fluoride (TBAF) is a lipophilic quaternary ammonium fluoride which has wide application in organic synthesis. TBAF is a silyl ether deprotection reagent having higher safety and stronger deprotection ability than other deprotection reagents (e.g., hydrofluoric acid, ammonium hydrogen fluoride complex, and fluorinated inorganic salts), and therefore has excellent performance.

Although TBAF has a very good advantage as a desiliconized ether protecting reagent, TBAF impurities are difficult to remove after the silicon protecting group is removed in nucleoside synthesis.

Disclosure of Invention

The application provides a method for removing tetrabutylammonium fluoride, which can partially or completely improve and even solve the problem that tetrabutylammonium fluoride impurities are difficult to separate from nucleosides which have hydroxyl groups protected by silicon protecting groups after deprotection.

The application is realized as follows:

in a first aspect, examples of the present application provide a method of preparing a nucleoside of interest.

The method comprises the following steps:

hydroxyl protection of selective positioning is carried out on the nucleoside starting material by utilizing a silicon protecting group to form a nucleoside modifier;

chemically reacting the nucleoside modification to produce a nucleoside precursor carrying a silicon protecting group which protects the hydroxyl group at the selected position;

removing silicon protecting groups in the nucleoside precursor by adopting tetrabutylammonium fluoride, and hydrolyzing to obtain a to-be-separated substance at least containing target nucleoside and tetrabutyl quaternary ammonium salt;

and separating tetrabutyl quaternary ammonium salt from the substance to be separated by using cation exchange resin to obtain the target nucleoside.

According to some examples of the application, the target nucleoside is a mononucleoside, an oligonucleotide formed by polymerization of a mononucleoside, or a polynucleotide; wherein the base moiety of the mononucleoside is adenine, guanine, cytosine, thymine, uracil or an unnatural base.

According to some examples of the present application, the silicon protecting group comprises TMS, TES, TBDMS, TIPS, TIPDS or TBDPS;

or when the hydroxyl groups at a plurality of selected positions are protected by silicon protecting groups, each silicon protecting group is independently selected from any one of TMS, TES, TBDMS, TIPS, TIPDS and TBDPS;

alternatively, the hydroxyl groups of the selected positions include any one or more of 2 ', 3 ' and 5 '.

According to some examples of the present application, a method for separating a target nucleoside from tetrabutyl quat in an isolate using a cation exchange resin comprises: column chromatography was performed using cation exchange resin.

In a second aspect, the present application exemplifies the use of a cation exchange resin as an adsorbent for removing tetrabutylammonium from a mixture containing at least nucleosides and tetrabutylammonium.

In a third aspect, the present application exemplifies a method for removing tetrabutylammonium fluoride, which can be used for separation of nucleoside modifications in which a hydroxyl group is protected with a silicon protecting group after the silicon protecting group is removed with tetrabutylammonium fluoride.

The method comprises the following steps:

the mixture obtained after removal of the silicon protecting group and after hydrolysis is mixed with a cation exchange resin.

According to some examples of the application, the nucleoside modification is reacted in a solution of tetrabutylammonium fluoride in tetrahydrofuran to remove the silicon protecting group, followed by hydrolysis to obtain a mixture.

According to some examples of the present application, the mixture is subjected to column chromatography using a cation exchange resin as a stationary phase and water as a mobile phase, so that tetrabutylammonium is adsorbed to the cation exchange resin and the nucleoside is eluted into the lower column solution.

According to some examples of the application, the cation exchange resin is used in an amount of 3 to 5 times the mass of the nucleosides in the mixture; and/or, during elution, directly flowing through the cation exchange resin chromatography column with the eluent.

According to some examples of the present application, nucleoside yields are above 50%; alternatively, the yield of nucleosides reaches 65% to 70%.

In the above implementation, the cation exchange resin provided in the examples of the present application is used as an adsorbent for the separation of the tetrabutyl product after the removal of the silicon protecting group for protecting the hydroxyl group. The scheme can be applied to preparation processes of various nucleosides, and can effectively relieve or even solve the problems of difficult subsequent purification and separation, low yield of target products and the like in the preparation process caused by using tetrabutylammonium fluoride as a deprotection agent.

Drawings

In order to more clearly illustrate the technical solutions in the embodiments or the prior art of the present application, the drawings used in the description of the embodiments or the prior art will be briefly described below.

FIG. 1 shows a chromatogram of a nucleoside product prepared in example 1 of the present application;

FIG. 2 shows a chromatogram of a nucleoside product prepared in example 2 of the present application;

FIGS. 3-1 and 3-2 show chromatograms of the nucleoside product produced in example 3 of the present application.

Detailed Description

In the preparation of biological materials such as nucleosides or nucleotides and their derivatives, protection of the hydroxyl group is usually involved to prevent it from being altered during the preparation process or to participate in the reaction or to allow a specific hydroxyl group to participate in the reaction. It is then "reduced" to a hydroxyl group by deprotecting the protecting group in a suitably selected step.

Therefore, the choice of hydroxyl protecting group and deprotecting reagent is particularly important.

In some practices, the hydroxyl protecting group is selected to be a silicon-containing organic such as a silyl ether or the like. There are also some other protection such as benzyl ether protection, alkoxymethyl ether protection or alkoxymethyl substituted ether protection and the like.

In the silyl ether protection scheme, the silicon-containing protecting group may be selected from TMS, TES, TBS, TBDMS, TIPS, TIPDS, TBDPS, or the like. This type of protecting group has the advantage of being easily protected, also deprotected/deprotected. Wherein the deprotection can be tetrabutylammonium fluoride (Bu)₄NF) and in addition there are some species that can provide acid-base conditions for removal. But the use of tetrabutylammonium fluoride is still particularly common.

Although the desilication protecting group of tetrabutylammonium fluoride works well, it causes great difficulty in the subsequent purification process. Such problems are particularly described in the synthesis of nucleic acids, nucleosides, and the like.

As a result of studies, the inventors found that this is because, after deprotection of tetrabutylammonium fluoride using a hydroxyl group-protected nucleoside using silyl ether, the nucleoside product and a tetrabutylammonium reactant (e.g., tetrabutylammonium quaternary salt, illustratively, tetrabutylammonium hydroxide) are in the same reaction system and both have relatively high polarities, making it difficult to obtain a purified nucleoside by separating the nucleoside from the tetrabutylammonium reactant.

Heretofore, the inventors have mainly conducted the treatment in the following manner:

1) removing the silica gel; however, the scheme causes great loss of products (nucleosides), and the products (nucleosides) are often removed only by multiple times of purification, so that the reagent consumption is large, the flow is complicated, and the time consumption is long;

2) reverse C18 chromatographic column preparation; the scheme also has the problems of large separation loss of products and low preparation efficiency.

3) Normal phase purification of chiral preparation column: the scheme has the problems of high price and high cost of the chiral preparation column.

Furthermore, the above schemes are generally specific, i.e., directed to a particular nucleoside substrate. Meanwhile, the schemes also have the defects of long separation period, incapability of realizing industrialized mass production and the like.

Therefore, there is an urgent need to develop a cost-effective and low product loss scheme for separating nucleoside and tetrabutyl reactants.

In other words, in view of the high medical value of nucleosides, the search for a convenient and rapid method for removing TBAF has been the direction of efforts of scientists.

In view of the above, a solution is proposed in the present application, which can satisfy the above-mentioned needs.

In general, the protocols in the examples of the present application were developed mainly for the technical problem of separation of nucleosides and their derivatives. The present exemplary embodiment proposes a method for achieving rapid removal of TBAF from nucleosides and their derivatives by cation exchange resins.

Embodiments of the present application will be described in detail below with reference to examples, but those skilled in the art will appreciate that the following examples are only illustrative of the present application and should not be construed as limiting the scope of the present application. The examples, in which specific conditions are not specified, were conducted under conventional conditions or conditions recommended by the manufacturer. The reagents or instruments used are not indicated by the manufacturer, and are all conventional products available commercially.

The following description will specifically describe a method for removing tetrabutylammonium fluoride in the examples of the present application.

In general, in the present disclosure, tetrabutylammonium (tetrabutylammonium hydroxide) is adsorbed using a cation exchange resin as an adsorbent, thereby removing tetrabutylammonium. Also, as an application in nucleoside synthesis, there is exemplified a scheme of removing tetrabutylammonium from a mixture containing at least nucleoside and tetrabutylammonium using a cation exchange resin, thereby obtaining a purified or isolated nucleoside product.

As an alternative, and as a partial example, in the case of a mononucleoside (as opposed to an oligonucleotide or a polynucleotide or a nucleotide or a derivative thereof, wherein the derivative may be a product of a group or element modification on a base or a ribose or phosphate group), the hydroxyl group thereof is protected with a silicon protecting group to constitute a nucleoside modification. When deprotecting a nucleoside modification, tetrabutylammonium fluoride is used as the deprotection reagent. Then the nucleoside product and tetrabutylammonium are obtained after hydrolytic combination, and fluoride formed by protective groups and fluorine is obtained.

The fluoride is less polar and can therefore be removed by beating with a less polar solvent or the less polar product (fluoride) can be extracted directly and separated from the nucleoside. However, since the polarity of nucleoside products and the polarity of tetrabutylammonium are both relatively high, it is difficult to separate them, at least by a silica gel column or a reversed phase C18 column.

In other words, after deprotection of the nucleoside modification, hydrolysis will yield at least nucleoside product, tetrabutylammonium impurity and fluoride impurity. Among them, fluoride impurities are easily separated from nucleoside products, whereas tetrabutylammonium impurities are difficult to separate, and the present exemplary embodiment can be used to separate nucleoside products and tetrabutylammonium impurities.

The present disclosure adopts the adsorption characteristics of cation exchange resins (macroporous strong acid cation resin LXC-105, macroporous strong acid cation resin LXC-107, us dow resin UP6150) for tetrabutylammonium impurities, so that nucleoside products and tetrabutylammonium impurities are adsorbed during the contact reaction of the cation exchange resins, whereas the nucleoside products can be obtained as a separated product without adsorption, thereby achieving purification.

In one example, the nucleoside is prepared by purification using cation exchange resin for column chromatography.

For example, the steps for preparing nucleosides can be referred to the following formulas 1 and 2.

In the above formula, Base represents a nucleoside Base, and may be a natural Base such as AGCTU, i.e., adenine, guanine, cytosine, thymine, uracil, etc.; or artificial/unnatural bases. Wherein, R₁、R₂、R₃、R₄And R₅Each represents a hydroxyl protecting group. Wherein R is₁Is a 5' hydroxy protecting group of a nucleoside, R₂Is a 3' hydroxy protecting group，R₃Is a 5' hydroxy protecting group, R₄Is a 3' hydroxy protecting group, R₅Is a 2' hydroxy protecting group. R is as defined above₁To R₅Each protecting group of (a) may be independently selected, and may be independently selected from:

TMS (trimethylsilyl group,)；

TES (triethylsilyl group,)；

TBDMS (TBS, tert-butyldimethylsilyl,)；

TIPS (tri-isopropyl-silicon-based,)；

TIPDS (1,1,3, 3-tetraisopropyldisiloxyl,)；

TBDPS (tert-butyl diphenyl silyl,)。

in the above formulas 1 and 2, two or three hydroxyl groups are protected and deprotected, respectively, but the scheme exemplified in the present application is also applicable to the case where only one hydroxyl group is selected for protection. In addition, in the above formula, a single nucleoside is used for exemplary illustration. However, the same applies in the case of polynucleotides or oligonucleotides or nucleotides and derivatives thereof, based on the present embodiment.

In the example given in the above reaction formula, the nucleoside modification (hydroxy protection) is reacted in a tetrahydrofuran solution of tetrabutylammonium fluoride to remove the silicon protecting group, and then directly (without concentration or purification) hydrolyzed (for example, deionized water is added to the reaction system in an amount of 5 to 10 times the volume of the reaction solution) to obtain a liquid mixture. Then taking cation exchange resin as a stationary phase and water as a mobile phase/eluent, and directly carrying out column chromatography on the mixture. This allows tetrabutylammonium to be adsorbed and attached to the cation exchange resin, and allows the nucleoside to be eluted and to enter the lower column solution. The lower column liquid may be further treated to remove fluoride therefrom. Alternatively, in other examples, fluoride is removed from the mixture prior to performing column chromatography.

Due to the differences in the properties of the fluoride and nucleoside products as they travel through the column, the column effluent can be monitored by means of UV measurements to allow for the collection of purer nucleoside products. Collecting the nucleoside from the lower column liquid by UV measurement; the nucleoside solid can then be directly concentrated to dryness.

In the above column chromatography, the amount of the cation exchange resin to be used may be selected depending on the amount of the nucleoside product in the lower column solution. In an example, however, the amount of cation exchange resin may be selected to be 3 to 5 times the mass of the nucleosides in the mixture. In such an amount, the elution efficiency and yield of nucleoside and the utilization rate of resin can be well balanced. Wherein the mass of nucleosides in the mixture can be determined by subjecting the mixture to a UV method. The nucleoside content is determined, for example, by the UV absorbance of the nucleoside organic in the mixture.

In particular, in the exemplary embodiment of the present application, when the elution operation of column chromatography is performed, the eluent may be used to directly flow through the cation exchange resin chromatography column. That is, the nucleoside product can be directly eluted into the column by elution without undergoing adsorption or desorption. In other words, in the elution process, there is no need to perform, for example, gradient elution (gradient elution requires preparation of eluents of different concentrations), and there is no fear that other impurities which are difficult to separate may be mixed into nucleosides.

In addition, in consideration of the fact that the cation exchange resin is easily contaminated during storage, transportation, etc., and the like, and the cation exchange resin is not effective or deteriorated, the cation exchange resin may be pretreated before elution. For example, after the cation exchange resin is packed in a column, pretreatment may be performed by alkali washing, water washing, and acid washing in this order. Illustratively, after packing the column, washing is carried out with 0.2N to 2.02N normality/0.2 mol/L to 2.02mol/L sodium hydroxide solution. The amount of sodium hydroxide solution used may be 5 times the volume of the packed column. The column is washed with water to remove the salt impurities and then acid washed with an acid solution (e.g., 0.2N to 2.0N equivalent/0.2 mol/L to 2mol/L hydrochloric acid) to ensure that the column is acidic.

The method can realize the removal of the tetrabutyl quaternary ammonium salt in the nucleoside synthesis process of removing the silyl ether protecting group (protecting hydroxyl group) by using tetrabutyl ammonium fluoride quickly, efficiently, simply and economically. The product recovery rate of the purification step using the ion exchange resin can be up to 50% or more, and in some examples, can be up to 60% to 70%, and the two-step (deprotection and purification) yield is 35 mol% to 45 mol%.

As described above, the solution of the present application has a better TBAF removal effect, and the solution of the present application also has at least some of the following features.

1. After the nucleoside compound is subjected to silicon removal protection by TBAF, the polarity of a nucleoside product is generally high, and when the nucleoside compound is separated and purified by silica gel, TBAF242 is very rich and can be purified only by 2-3 times of purification, which very easily causes the purity deficiency.

The scheme of the application adopts cation exchange resin (cation resin) to adsorb tetrabutylammonium for the first time, and directly obtains a purified nucleoside product. The product obtained by the method has small solvent dosage (for example, the dosage of eluent is small when column chromatography is carried out), the process is simple, the tetra-n-butylamine 242 can be relatively and thoroughly removed, and the method can be applied to large-scale industrial production.

2. The application of the embodiment directly adopts nontoxic and harmless water for elution, avoids using organic solvents such as ethyl acetate, dichloromethane/methanol, acetonitrile and the like, saves industrial cost and is suitable for industrial mass production. Because the elution can be directly carried out by flowing through the chromatographic column, the elution system is better, simple and easy to implement and process monitoring, and is convenient for industrial production.

3. The yield of the traditional TBAF deprotection reaction after silica gel purification/C18 reversed phase purification is about 40-50%, and the yield is low. The method directly penetrates the product stream to directly obtain a purified product, and the yield can reach 65-70%.

4. The method has platform significance for the method transfer of the cation resin stable substrate by using the cation resin for removing tetra-n-butyl ammonium fluoride (TBAF) for the first time.

In the above exemplary scheme, a purification process is employed in which a single nucleoside having a defined structure is deprotected with tetrabutylammonium fluoride. However, it will be appreciated that the protocol can be applied equally well to the synthesis of oligo-or polynucleosides.

Accordingly, there can be proposed a method for producing a target nucleoside, which comprises:

and step S1, hydroxyl protection of the selected position of the nucleoside starting material is carried out by utilizing a silicon protecting group to form the nucleoside modifier.

The nucleoside starting material can be any type of nucleoside, or nucleoside intermediate or nucleoside derivative or nucleotide derivative modified with other functional groups; no particular limitation is imposed on this disclosure.

Step S2, a chemical reaction is performed on the nucleoside modification to prepare a nucleoside precursor carrying a silicon protecting group protecting the hydroxyl group at the selected position.

Such as the polymerization of nucleosides, or the substitution of specific groups, or the phosphorylation of binding agents to make nucleotides, among others.

And step S4, removing silicon protecting groups in the nucleoside precursor by using tetrabutylammonium fluoride, and hydrolyzing to obtain a to-be-separated substance at least containing the target nucleoside and tetrabutyl quaternary ammonium salt.

Since fluorine has a strong affinity with silicon, therefore,the bonding property of the two is stronger than the structural property of the silicon ether protecting group and oxygen. Thus, when the silicon protecting group is removed using tetrabutylammonium fluoride, fluorine can be combined with the silicon protecting group to form a fluoride (for example, when TMS (trimethylsilyl) is used as a hydroxyl protecting group, trimethylfluorosilane can be obtained,) Whereas tetrabutyl can bind to the hydroxyl oxygen on the nucleoside and can be "reduced" by hydrolysis to give the hydroxyl bound to the nucleoside and free tetrabutylammonium (tetrabutylammonium hydroxide). Thus, fluoride, tetrabutylammonium, nucleosides, and the like may be present in the isolate.

And step S5, separating tetrabutyl quaternary ammonium salt from the object to be separated by using cation exchange resin to obtain the target nucleoside.

Among the schemes for separation using cation exchange resins is, for example, column chromatography as described above. The stationary phase is cation exchange resin, and the mobile phase can be flexibly selected according to nucleoside substrate, reagent used in the reaction process, and the like, which is not specifically limited by the disclosure.

A method for removing tetrabutylammonium fluoride according to the present application is further described in detail with reference to the following examples.

Example 1

A method for removing TBAF in the synthesis of 3' -Bz-A (N-Bz).

The "reduction" of the 5' hydroxyl group is carried out as above, wherein the hydrolysis step is omitted.

5 '-O-TBDMS-3' -O-Bz-A (N-Bz) (6.45kg,1eq) was used as a raw material, THF (28.7kg) was used as a reaction solvent, tetrabutylammonium fluoride (3.73kg, 1.2eq) was used as a reagent, and the reaction was carried out at 30 ℃ for 16 hours.

After the completion of the reaction, UPLC monitors that the reaction solution is directly added with deionized water (5V) without concentration to form a sample solution, and the nucleoside content of the sample solution is determined by a UV method.

A column was packed with a cation exchange resin column (U.S. Dow resin UP6150) having a mass 5 times that of the nucleoside to prepare a column. And then, deionized water is used as eluent for column chromatography purification, and qualified injection (the injection with HPLC purity of more than or equal to 98.5 percent is qualified injection) is directly concentrated and taken to obtain 2.75kg of product with purity of 99.0 percent and weight yield of 43 percent, and the product purity data is shown in figure 1.

Example 2

A method for removing TBAF in the synthesis of 3' -Bz-Ur.

The "reduction" of the 5' hydroxyl group is carried out as above, wherein the hydrolysis step is omitted.

5 '-O-TBDMS-3' -O-Bz-Ur (2kg,1eq) is used as a raw material, THF (9kg) is used as a reaction solvent, and tetrabutylammonium fluoride (1.3kg, 1.2eq) is used as a reagent, and the reaction is carried out for 16 hours at the temperature of 30 ℃.

After the completion of the reaction, UPLC monitors that the reaction solution can be directly added with deionized water (10V) sample loading solution without concentration, and the nucleoside content of the sample loading solution is determined by a UV method.

A column was packed with a cation exchange resin column (U.S. Dow resin UP6150) having a mass 5 times that of the nucleoside to prepare a column. And then, deionized water is used as eluent for column chromatography purification, and qualified bottom pouring liquid is directly concentrated to 1kg of product, the purity is 99.9 percent, and the weight yield is 50 percent. The product purity data are shown in FIG. 2.

Example 3

The "reduction" of the 5' hydroxyl group is carried out as above, wherein the hydrolysis step is omitted.

5 '-O-TBDMS-3' -O-Bz-Cr (2kg,1eq) is used as a raw material, THF (9kg) is used as a reaction solvent, and tetrabutylammonium fluoride (1.2kg, 1.2eq) is used as a reagent, and the reaction is carried out for 16 hours at the temperature of 30 ℃.

After the completion of the reaction, UPLC monitors that the reaction solution can be directly added with deionized water (10V) sample loading solution without concentration, and the nucleoside content of the sample loading solution is determined by a UV method.

A column was packed with a cation exchange resin column (U.S. Dow resin UP6150) having a mass 5 times that of the nucleoside to prepare a column. And then, deionized water is used as eluent for column chromatography purification, and qualified bottom pouring liquid is directly concentrated to 0.9kg, the purity is 99.5 percent, and the weight yield is 45 percent. The product purity data are shown in FIGS. 3-1 and 3-2.

The above description is only a preferred embodiment of the present application and is not intended to limit the present application, and various modifications and changes may be made by those skilled in the art. Any modification, equivalent replacement, improvement and the like made within the spirit and principle of the present application shall be included in the protection scope of the present application.